Not a good buy right now for an impatient entry: price ($32.13) has sprinted above R1 (31.59) and is now close to R2 (33.18) while RSI is extremely overbought, making near-term pullback risk high.
Wall Street targets cluster around ~$25–$29 (mostly Neutral/Hold) which is below the current price, implying limited upside vs. consensus view.
Options flow is aggressively call-skewed today (very bullish near-term), but fundamentals and demand commentary remain soft; that’s a setup where a pop can fade.
Net: I would wait for a dip closer to the low-30s/high-20s support zone; at this level it’s a HOLD/avoid chasing rather than a BUY.
Technical Analysis
Trend: Bullish structure with SMA_5 > SMA_20 > SMA_200, confirming a strong short-to-long term upswing.
Momentum: MACD histogram +0.27 and expanding → momentum still rising.
Overbought: RSI(6) = 86.9 → very overbought; near-term mean reversion risk is elevated.
Levels: Pivot 29.02; Support S1 26.44; Resistance R1 31.59 already cleared; next resistance R2 33.18 (nearby).
Tactically: After a +5.44% regular-session jump, the risk/reward for a new buy is poor until consolidation or a pullback.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning/Sentiment: OI put/call 0.87 → slightly more call open interest than puts (mildly bullish).
Today’s flow: Volume put/call 0.07 with calls ~65,996 vs puts ~4,391 → extremely call-heavy (bullish/“risk-on” tone).
Activity spike: Today’s options volume ~70,387 vs 30D average (238.8%) → unusually active session, often tied to event/reaction trading.
Volatility: 30D IV 48.38 vs HV 41.71 → IV premium suggests the market is pricing elevated near-term moves; not cheap optionality.
Technical Summary
Sell
3
Buy
9
Positive Catalysts
Sector tailwind: S&P 500 Materials Index gained +8.64% in January, improving tape/sector momentum.
Company actions: New program targeting +$2B EBITDA improvement (restructuring/cost and asset rationalization) can amplify earnings when demand recovers.
Options sentiment: Very call-skewed volume today suggests traders are leaning bullish in the near term.
Earnings: EPS -2.19 (still a loss); net income -$1.543B (still negative). Despite YoY “increase” vs a worse prior period, the business is not yet showing clean earnings recovery.
Operations: Q4 operating EBITDA reported at $741M (down, reflecting weaker seasonal demand) → confirms the trough-like conditions management/analysts are discussing.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend: A wave of price-target increases after Q4 (UBS to $28 from $23; Jefferies to $28 from $23; RBC to $29 from $25; Citi to $28 from $27; Mizuho to $27 from $25), but ratings largely stayed Neutral/Hold/Sector Perform.
What pros like: Potential 2H26 demand recovery, polyethylene margin improvement/normalized supply, and restructuring/cost actions that could magnify earnings in a rebound.
What pros dislike: End-market trends remain weak/muted near-term; oversupply risk in commodity chemicals; recovery catalysts seen as early/uncertain.
Practical takeaway: Even after target bumps, consensus targets remain below today’s price—Wall Street is not signaling “buy-the-breakout” here.
Influential trading check: No recent Congress trading data available; insiders are neutral with no significant recent trend.
Wall Street analysts forecast DOW stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for DOW is 25.71 USD with a low forecast of 20 USD and a high forecast of 32 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
15 Analyst Rating
Wall Street analysts forecast DOW stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for DOW is 25.71 USD with a low forecast of 20 USD and a high forecast of 32 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
13 Hold
1 Sell
Hold
Current: 30.600
Low
20
Averages
25.71
High
32
Current: 30.600
Low
20
Averages
25.71
High
32
Citi
Patrick Cunningham
Neutral
maintain
$27 -> $28
AI Analysis
2026-02-02
Reason
Citi
Patrick Cunningham
Price Target
$27 -> $28
AI Analysis
2026-02-02
maintain
Neutral
Reason
Citi analyst Patrick Cunningham raised the firm's price target on Dow Inc. to $28 from $27 and keeps a Neutral rating on the shares.
UBS
Joshua Spector
Neutral
maintain
$23 -> $28
2026-01-30
Reason
UBS
Joshua Spector
Price Target
$23 -> $28
2026-01-30
maintain
Neutral
Reason
UBS analyst Joshua Spector raised the firm's price target on Dow Inc. to $28 from $23 and keeps a Neutral rating on the shares.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for DOW
